| Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation S Weilner, S Skalicky, B Salzer, V Keider, M Wagner, F Hildner, C Gabriel, ... Bone 79, 43-51, 2015 | 204 | 2015 |
| Vesicular Galectin-3 levels decrease with donor age and contribute to the reduced osteo-inductive potential of human plasma derived extracellular vesicles S Weilner, V Keider, M Winter, E Harreither, B Salzer, F Weiss, E Schraml, ... Aging (Albany NY) 8 (1), 16, 2016 | 97 | 2016 |
| GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ... Cancer Cell 40 (1), 53-69. e9, 2022 | 96 | 2022 |
| Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR function B Salzer, CM Schueller, CU Zajc, T Peters, MA Schoeber, B Kovacic, ... Nature Communications 11 (1), 4166, 2020 | 68 | 2020 |
| A conformation-specific ON-switch for controlling CAR T cells with an orally available drug CU Zajc, M Dobersberger, I Schaffner, G Mlynek, D Pühringer, B Salzer, ... Proceedings of the National Academy of Sciences 117 (26), 14926-14935, 2020 | 64 | 2020 |
| Driving CARs with alternative navigation tools–the potential of engineered binding scaffolds CU Zajc, B Salzer, JM Taft, ST Reddy, M Lehner, MW Traxlmayr The FEBS journal 288 (7), 2103-2118, 2021 | 27 | 2021 |
| A preclinical embryonic zebrafish xenograft model to investigate CAR T cells in vivo S Pascoal, B Salzer, E Scheuringer, A Wenninger-Weinzierl, C Sturtzel, ... Cancers 12 (3), 567, 2020 | 26 | 2020 |
| Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors J Burton, JA Siller-Farfán, J Pettmann, B Salzer, M Kutuzov, ... Proceedings of the National Academy of Sciences 120 (2), e2216352120, 2023 | 21 | 2023 |
| Directed evolution of stabilized monomeric CD19 for monovalent CAR interaction studies and monitoring of CAR-T cell patients E Laurent, A Sieber, B Salzer, A Wachernig, J Seigner, M Lehner, ... ACS Synthetic Biology 10 (5), 1184-1198, 2021 | 13 | 2021 |
| A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells CU Brey, J Proff, N Teufert, B Salzer, J Brozy, M Münz, J Pendzialek, ... Scientific Reports 8 (1), 17453, 2018 | 13 | 2018 |
| Getting CD19 into shape: expression of natively folded “difficult-to-express” CD19 for staining and stimulation of CAR-T cells E Lobner, A Wachernig, V Gudipati, P Mayrhofer, B Salzer, M Lehner, ... Frontiers in Bioengineering and Biotechnology 8, 49, 2020 | 12 | 2020 |
| Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide K Byrgazov, C Anderson, B Salzer, E Bozsaky, R Larsson, J Gullbo, ... Therapeutic Advances in Medical Oncology 12, 1758835920937891, 2020 | 10 | 2020 |
| The frequency of differentiated CD3+CD27-CD28- T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma N Worel, K Grabmeier-Pfistershammer, B Kratzer, M Schlager, ... Frontiers in Immunology 13, 1004703, 2023 | 9 | 2023 |
| The ligand-dependent suppression of TCR signaling by the immune checkpoint receptor LAG3 depends on the cytoplasmic RRFSALE motif K Aigner-Radakovics, A De Sousa Linhares, B Salzer, M Lehner, S Izadi, ... Science Signaling 16 (805), eadg2610, 2023 | 5 | 2023 |
| Interrogating ligand-receptor interactions using highly sensitive cellular biosensors MA Funk, J Leitner, MC Gerner, JM Hammerler, B Salzer, M Lehner, ... Nature Communications 14 (1), 7804, 2023 | 2 | 2023 |
| An engineering strategy to target activated EGFR with CAR T cells M Dobersberger, D Sumesgutner, CU Zajc, B Salzer, E Laurent, ... Cell Reports Methods 4 (4), 2024 | 1 | 2024 |
| Preclinical testing of CAR T cells in zebrafish xenografts S Grissenberger, B Salzer, S Pascoal, A Wenninger-Weinzierl, M Lehner, ... Methods in Cell Biology 167, 133-147, 2022 | 1 | 2022 |
| ENGINEERING AVIDCARS FOR COMBINATORIAL ANTIGEN RECOGNITION S Balaji, B Salzer, C Schueller, C Zajc, M Traxlmayr, M Lehner HUMAN GENE THERAPY 34 (21-22), A13-A13, 2023 | | 2023 |
| TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation T Peters, V Mühlgrabner, RMHV Cárdenas, R Platzer, J Göhring, B Salzer, ... bioRxiv, 2023.03. 16.532775, 2023 | | 2023 |
| ENGINEERING AVIDCARS FOR COMBINATORIAL ANTIGEN RECOGNITION M Lehner, B Salzer, C Schueller, C Zajc, M Traxlmayr HUMAN GENE THERAPY 33 (7-8), A18-A19, 2022 | | 2022 |
